A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

NCT00919854 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus 1

Interventions

DRUG: Darunavir
DRUG: Ritonavir

Sponsor

Tibotec Pharmaceuticals, Ireland

Collaborators

[object Object]